Calliditas Therapeutics AB (publ) CALT
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| ASAHI KASEI CORPORATION | Japan | 53156176 | 0 | 53156176 | 0 | 53156176 | 98.38 % | 23/09/2024 |
| ASAHI KASEI CORPORATION | Japan | 5367206 | 23964005 | 5367206 | 23964005 | 29331211 | 54.6 % | 04/06/2024 |
| Swedbank Robur Fonder AB | 0 | 0 | 0 | 0 | 0 | 0 % | 26/01/2023 | |
| Linc AB | Sweden | 0 | 5486108 | 0 | 0 | 5486108 | 10.5 % | 02/03/2022 |
| Bengt Julander | Sweden | 0 | 5486108 | 0 | 0 | 5486108 | 10.5 % | 02/03/2022 |
| Fjärde AP-fonden (Fourth Swedish National Pension Fund) | Sweden | 0 | 2675000 | 0 | 0 | 2675000 | 5.1 % | 14/02/2022 |
| Swedbank Robur Fonder AB | 2638107 | 0 | 2638107 | 0 | 2638107 | 5.04 % | 14/02/2022 | |
| BVF Inc. | Delaware | 0 | 0 | 0 | 4781562 | 4781562 | 9.7 % | 08/06/2020 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 4781562 | 4781562 | 9.7 % | 08/06/2020 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 2464491 | 2464491 | 5 % | 08/06/2020 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 2464491 | 2464491 | 5 % | 08/06/2020 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 1884971 | 1884971 | 3.8 % | 08/06/2020 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 1884971 | 1884971 | 3.8 % | 08/06/2020 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 327358 | 327358 | 1 % | 08/06/2020 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 327358 | 327358 | 1 % | 08/06/2020 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 0 | 0 | 4349462 | 4349462 | 8.8 % | 08/06/2020 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 4781562 | 4781562 | 9.7 % | 08/06/2020 |